As of 2023, the global minimally invasive neurosurgery devices market stands at a valuation of USD 3,227.9 million. Forecasts suggest a consistent upward trend, with an estimated average CAGR of 6.3% anticipated from 2023 to 2033. This trajectory is poised to propel the market beyond USD 5,950.1 million by 2033.
Key Highlights
| Attributes | Details |
|---|---|
| Minimally Invasive Neurosurgery Devices Market Size (2023) | USD 3,227.9 million |
| Minimally Invasive Neurosurgery Devices Market Projected Size (2033) | USD 5,950.1 million |
| Forecasted Value CAGR (2023 to 2033) | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Neurological Conditions are on the Surge Globally: Neurological conditions remain to be considered among the leading causes of impairment globally, and their proportion to the overall burden of all health problems is growing. An estimated 22.6 million people each year suffer from neurological illnesses or traumas that need the skills of a neurosurgeon, with 13.8 million requiring surgery. The invasiveness and efficacy of therapies have emerged as top concerns for people suffering from neurosurgery. When compared to traditional open surgery, minimally invasive procedures often result in smaller incisions, less blood loss, and quicker recovery times. Patients are receiving medical care distinctively as a result of minimally invasive treatments. Several minimally invasive neurosurgery devices like endoscopes are frequently used by neurosurgeons to undertake minimally invasive evaluations and surgical operations.
Minimally Invasive Surgery Gains Prominence amid Global Aging Trends: Modern civilization is defined by an aging population and a more complicated way of living. According to a World Health Organization study published in October 2021, one out of every six persons on the earth is projected to reach 60 or older by 2030. The number of older individuals requiring various surgical procedures is predicted to increase as the general population ages. Minimally invasive brain surgery is particularly beneficial for older patients, as they tend to have fewer complications and a faster recovery. Patients have practically little discomfort because no incisions are required, and they frequently return home after a brief hospital stay.
Minimally Invasive Procedures Reduce Healthcare Costs: Minimally invasive procedures often lead to shorter hospital stays and quicker recovery times. This simultaneously reduces overall healthcare costs. When patients spend less time in the hospital, they do not have to pay as much for things like a hospital bed or medicine. Hospitals also save money because they use fewer resources. Therefore, it is cheaper for both patients and hospitals. This is a big reason why doctors and hospitals like to use minimally invasive devices for brain stereotactic surgery and other neurosurgery. This cost-effectiveness is a key driver for the minimally invasive neurosurgery devices market.
Accessible Healthcare is Transforming Neurosurgery Landscape: The accessibility of advanced healthcare technologies, including minimally invasive neurosurgery devices, has improved in many parts of the world. Both developing and developed countries' healthcare expenditures are growing. In developing countries, inadequate utilization of public health care is highly widespread. Fortunately, there has been an increasing priority of late on building low-income countries' healthcare facilities. Regulatory bodies in various regions have been supportive of technological advancements in the healthcare industry. This has facilitated the development and approval of these devices. This globalization of healthcare has expanded the minimally invasive neurosurgery devices market.
Technological Advancements are Transforming Neurosurgery with Minimally Invasive Techniques: Less invasive and minimally invasive therapy is now the dominant trend in the advancement of modern clinical care. The continuous evolution of technology has led to the development of more precise neurosurgical devices. For instance, with the advancement of current technological developments and the ongoing advancement of clinical medicine, researchers have employed neurosurgical robotics in minimally invasive puncture surgery, boosting the procedure's precision, effectiveness, and safety. Augmented Reality and Artificial Intelligence have begun to be integrated into these minimally invasive therapies. The ease of recovery and faster restoration after surgery make it a highly effective treatment technique. Several patients opt for minimally invasive neurosurgery over typical surgical therapies. Therefore, the demand for minimally invasive neurosurgery devices is skyrocketing.
Between 2017 and 2022, the minimally invasive neurosurgery devices market experienced significant growth, climbing from USD 2,516.7 million to USD 3,073.9 million, showcasing a consistent 4.1% CAGR. Increasing awareness about the benefits of minimally invasive procedures was driving the market forward during this period. However, this period witnessed a slower CAGR than the forecast period as there had been a higher reliance on traditional, open surgical methods. Transitioning to new treatments takes time because medical practitioners need to develop trust in the effectiveness and safety of these minimally invasive techniques.
| Attributes | Details |
|---|---|
| Minimally Invasive Neurosurgery Devices Market Size (2017) | USD 2,516.7 million |
| Minimally Invasive Neurosurgery Devices Market Size (2022) | USD 3,073.9 million |
| Historical Value CAGR (2017 to 2022) | 4.1% |
Looking forward to 2033, projections suggest a healthier pace, with the market size anticipated to rise from USD 3,227.9 million in 2023 to USD 5,950.1 million by 2033, reflecting a steady 6.3% CAGR. It demonstrates a sustained upward trend in demand and innovation within the industry. The ease of recovery and faster healing after surgery make it a more successful treatment technique. Several individuals prefer minimally invasive neurosurgery to standard surgical procedures.
The projection shows that there is room for more research and development in this field. It also means there are opportunities for stakeholders to explore new avenues for improving patient outcomes and expanding their market presence. In general, the future looks strong for minimally invasive neurosurgery devices. Both doctors and patients are likely to witness better results and options in the future.
Key minimally invasive neurosurgery devices market participants are creating and inventing innovative devices with contemporary technologies. Ambu Inc., for example, got Health Canada certification for aScope 4 Cysto, a one-time-use endoscope system for urology, in April 2021. In another development, in April 2021, Olympus Corporation, working alongside Veran Medical Technologies Inc., announced the United States bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a range of five extravagant endoscopes for application in advanced treatments and diagnostics. As a result, such initiatives are expected to generate opportunities for minimally invasive neurosurgery device innovation and development. This is likely to fuel the minimally invasive neurosurgery devices market expansion throughout the forecast period.
Principal Consultant
| Attributes | Details |
|---|---|
| Trends |
|
| Opportunities |
|
In 2022, North America solidified its leading position in the global minimally invasive neurosurgery devices market, securing an impressive 37.1% market share. Following closely behind, Europe held a substantial 26.8% share, underlining its noteworthy presence in the industry. This data underscores the significant strides made by both regions in advancing neurosurgical techniques through minimally invasive approaches.
| Countries | 2022 Value Share in Global Market |
|---|---|
| United States | 33.7% |
| Germany | 8.7% |
| Japan | 4.1% |
North America has had a significant share of the minimally invasive neurosurgery devices market in recent years, and this trend is likely to continue during the projection period. This is due to the high prevalence of illnesses needing minimally invasive treatments and increased awareness of minimally invasive surgery. Minimally invasive neurosurgery has witnessed a significant surge in demand within the United States over the past decade. Given the substantial prevalence of chronic diseases such as neurovascular and neurological disorders, the United States is likely to have a significant market share over the projection period. For example, as per CDC data revised in October 2022, every 34 seconds, an individual in the United States suffers from neurovascular disease, indicating a significant burden of the illness in the country and the need for procedures. This is likely to increase demand for minimally invasive surgical techniques in the United States and drive market growth during the forecast period.
The United States boasts a well-established healthcare infrastructure and a robust medical device industry. Technological developments in different surgical devices utilized for MIS created by leading market competitors are likely to complement the region's market expansion. For example, the Food and Drug Administration authorized the NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) system for premarketing in May 2021. Furthermore, Misonix Inc., a producer of minimally invasive therapeutic high-frequency medical devices and rehabilitative products, obtained authorization for the neXus Ultrasonic Surgical System in March 2021. neXus is a potent, comprehensive, and simple-to-use device that incorporates modern and recent breakthroughs in ultrasonic technology for enhanced efficiency and efficacy in treating operations across several surgeries. As a result, such product introductions are expected to stimulate regional market expansion.
Developed nations, such as Germany, are far more aware of these technological technologies and have a significantly greater adoption rate than those in other nations. The growth in the proportion of neurosurgeons per 100,000 people in Germany, from 1.18 in 2000 to 2.94 in 2019, has substantially influenced the minimally invasive neurosurgery devices market. This increase in neurosurgeon availability reflects a greater emphasis on neurosurgical treatment as well as technical developments in the area. Spinal injuries are more common among the elderly. As a result, more senior patients are concerned about back discomfort and other structural joint problems. Minimally invasive orthopedic neurosurgeries like spinal endoscopy are used to treat or rectify musculoskeletal damage in both surgical and nonsurgical settings. These procedures are predicted to expand in Germany due to the country's large senior population, which is expected to grow in the future. Furthermore, a high adoption rate and need for less invasive treatments are projected to boost the minimally invasive neurosurgery devices market expansion in Germany.
The increased frequency of lifestyle-related and chronic illnesses, technology improvements, and Japan's growing senior population are all driving the minimally invasive neurosurgery devices market expansion. According to the IDF's 2022 data, 11 million Japanese persons were diagnosed with diabetes in 2021 which is expected to rise considerably by 2030. Diabetes-related elevated blood sugar levels can harm the nerves that regulate the heart and blood vessels, leading to cardiovascular disorders such as coronary artery disease, stroke, and arterial constriction. This is expected to increase demand for surgical operations and consequently feed demand for minimally invasive cardiac neurosurgery devices. In 2018 and 2019, respectively, the neurosurgery division conducted 207783 and 225217 neurosurgical operations. This surge in surgical procedures underscores a growing demand for neurosurgical interventions in the region.
| Countries | Value CAGR between 2023 and 2033 |
|---|---|
| United Kingdom | 4.4% |
| India | 6.2% |
| China | 7.6% |
In the United Kingdom, the prevalence of neurological operations is low. In the previous year, the percentage of admissions receiving a neurosurgical operation in the United Kingdom was 77.3%.Although the in-hospital fatality rate following elective neurosurgery is low, there seems to be potential for improving quality to enhance mortality for non-elective surgery while assuring equal access to treatment. The increasing number of people with persistent medical conditions and technology improvements in the United Kingdom are anticipated to raise demand for minimally invasive surgery equipment. According to the 'British Association of Aesthetic Plastic Surgeons (BAAPS)' study issued in February 2021, around 15 thousand cosmetic procedures were performed in the United Kingdom in 2021. Such occurrences signify increased demand for minimally invasive operations in this country, which is favorable to the minimally invasive neurosurgery devices market growth. As a result of the aforementioned causes, demand for minimally invasive cosmetic neurosurgery devices is likely to rise throughout the forecast period.
There were 687 neurosurgery admissions in India in 2020. Hence, there is a corresponding need for advanced and precise minimally invasive neurosurgery microscopes. Furthermore, this trend signals a positive shift in the landscape of neurological healthcare in India. It reflects an increased focus on addressing neurological conditions and disorders. Increased obesity, investments, and awareness are projected to drive segment growth. According to a May 2021 paper published in the journal Neurosciences, the prevalence of obesity in India is 40.3%. As persons with obesity frequently have cosmetic procedures, the country's high population of obese people is expected to drive the growth of the minimally invasive bariatric neurosurgery devices market over the projected period. The top neurosurgical hospitals are in the United Kingdom and the United States; however, they are highly expensive. The cost of brain biopsy and spine-related surgeries in India is 40 to 50% of what they are in the United States, the United Kingdom, and other developed countries. Given its outstanding neurosurgeon skills, an experienced and competent operative and post-operative care team, world-class surgical and hospital amenities, the capacity to cope with difficult surgeries, and affordable rates, India is establishing itself as one of the top choices for neurosurgery treatments.
With the fast expansion of China’s economy, neurosurgery has advanced tremendously in China during the previous decade. With the emergence of microscopic neurosurgery, neurosurgery in China reached the age of micro-neurosurgery. The prevalence of endovascular neurosurgery in China is 1,114.8 per 100,000, the maximum in the world, and the fatality rate is 149.49 per 100,000, only second to cancer and heart disease. In the past few years, China's rapidly aging population and growing income level have focused attention on the country's healthcare system. As per the South China Morning Post, China's aging dilemma is worsening as the percentage of new births falls. According to the same source, China recorded 280.04 million individuals over the age of 60 at the end of last year, an increase from 267.36 million or 18.9 percent of the overall population at the end of 2021. These statistics underscore the pressing need for precise neurosurgical interventions, thus driving the demand for minimally invasive neurosurgery devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The minimally invasive neurosurgery devices market is segmented by device type into surgical devices, monitoring & visualization devices, and endoscopy devices. The monitoring & visualization devices segment dominated the global market in 2022, accounting for a 37.7% share. In a similar vein, when considering the surgery type, the minimally invasive neurosurgery devices market is categorized into urological neurosurgery devices, vascular neurosurgery devices, cardiac neurosurgery devices, gynecological neurosurgery devices, gastrointestinal neurosurgery devices, cosmetic neurosurgery devices, bariatric neurosurgery devices, thoracic neurosurgery devices, breast neurosurgery devices, and orthopedic neurosurgery devices. Notably, the gastrointestinal neurosurgery devices segment took the lead, commanding an impressive 28.8% market share in 2022.
| Segment | 2022 Value Share in Global Market |
|---|---|
| Monitoring & Visualization Devices | 37.7% |
| Gastrointestinal Neurosurgery Devices | 28.8% |
Given its critical role in improving surgical accuracy and patient satisfaction, monitoring & visualization devices dominate the minimally invasive neurosurgery devices market. These technologies give neurosurgeons real-time, high-definition intraoperative imaging and monitoring capabilities during surgeries. This allows them to get around delicate brain structures with unrivaled precision. Hence, they help to reduce the danger of tissue injury. Furthermore, in recent years, minimally invasive neurosurgery monitoring & visualization devices have witnessed substantial technical breakthroughs. This involves incorporating revolutionary imaging modalities like intraoperative MRI and 3D cranial navigation system. These advancements strengthen its position as the favored option among neurosurgeons globally. Furthermore, healthcare practitioners are becoming more aware of the long-term benefits of investing in these technologies. They help to enhance patient happiness and results. This leads to cost savings through shorter hospital stays and post-operative care.
As a result of significant lifestyle changes, gastrointestinal diseases have increased over the last decade. Numerous studies have found that persons with gastrointestinal illnesses are more likely to suffer from depression, stress, anxiety, and central nervous system dysfunction. Flooded streets, poor sanitation, and contaminated water sources have spread different gastrointestinal infections in developing countries. Moreover, when it comes to developed countries, the combination of a fast-paced lifestyle, improper dietary choices, and late-night eating leads to multiple gastrointestinal issues. Given this escalating health concern, there has been an evident surge in the demand for minimally invasive gastrointestinal neurosurgery devices. These advanced medical technologies offer less invasive approaches to treating gastrointestinal disorders. They also minimize trauma to the patient and expedite recovery. As a result, minimally invasive gastrointestinal neurosurgery devices have become a crucial component in the modern medical landscape.
Many market players have taken various measures. They create new devices and expand their businesses. They correspondingly make continuous investments to introduce improved devices. They also form strategic alliances with hospitals, research institutions, and other healthcare stakeholders. These strategies help them maintain their footing in the highly competitive industry.
Recent Developments in the Minimally Invasive Neurosurgery Devices Market
The global minimally invasive neurosurgery devices market is valued at USD 3,227.9 million in 2023.
The global minimally invasive neurosurgery devices market size is projected to surpass USD 5,950.1 million by 2033, recording a 6.3% CAGR.
The top minimally invasive neurosurgery device companies include Karl Storz GmbH & Co. KG, Olympus Corporation, and Conmed Corporation.
Minimally invasive neurosurgery devices include surgical devices, monitoring & visualization devices, and endoscopy devices.
Countries driving demand for minimally invasive neurosurgery devices are the United States, Germany, Japan, China, and India.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device Type 5.1. Surgical Devices 5.2. Neurosurgery Monitoring & Visualization Devices 5.3. Neurosurgery Endoscopy Devices 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Surgery Type 6.1. Urological Neurosurgery Devices 6.2. Vascular Neurosurgery Devices 6.3. Cardiac Neurosurgery Devices 6.4. Gynaecological Neurosurgery Devices 6.5. Gastrointestinal Neurosurgery Devices 6.6. Cosmetic Neurosurgery Devices 6.7. Bariatric Neurosurgery Devices 6.8. Thoracic Neurosurgery Devices 6.9. Breast Neurosurgery Devices 6.10. Orthopedic Neurosurgery Devices 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Karl Storz GmbH & Co. KG 17.2. Olympus Corporation 17.3. Conmed Corporation 17.4. Richard Wolf GmbH 17.5. Boston Scientific Inc. 17.6. Integra LifeSciences Holdings Corporation 17.7. Aesculap Division 17.8. Smith & Nephew Plc 17.9. Medtronic 17.10. NICO Corp. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Minimally Invasive Neurosurgery Devices Market
